Cyclophosphamide is indicated for the treatment of malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides (advanced disease), neuroblastoma (disseminated disease), adenocarcinoma of the ovary, retinoblastoma, and carcinoma of the breast. It is also indicated for the treatment of biopsy-proven minimal change nephrotic syndrome in pediatric patients
CYCLOPHOSPHAMIDE
Structure
Product Description
Details |
|
|---|---|
Chemical Name |
CYCLOPHOSPHAMIDE |
IUPAC Name |
(RS)-N,N-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide |
CAS Number |
50-18-0 |
Molecular Formula |
C7H15CI2N2O2P |
Synonyms |
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester monohydrate |
Application |
Oncology |